IN2012DN06279A - - Google Patents
Info
- Publication number
- IN2012DN06279A IN2012DN06279A IN6279DEN2012A IN2012DN06279A IN 2012DN06279 A IN2012DN06279 A IN 2012DN06279A IN 6279DEN2012 A IN6279DEN2012 A IN 6279DEN2012A IN 2012DN06279 A IN2012DN06279 A IN 2012DN06279A
- Authority
- IN
- India
- Prior art keywords
- rosacea
- receptor
- cxcl5
- chemokines
- interleukin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6869—Interleukin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28211309P | 2009-12-17 | 2009-12-17 | |
| PCT/EP2010/069896 WO2011073321A1 (en) | 2009-12-17 | 2010-12-16 | Markers and method for the diagnosis of rosacea |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN06279A true IN2012DN06279A (de) | 2015-09-25 |
Family
ID=43417037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN6279DEN2012 IN2012DN06279A (de) | 2009-12-17 | 2010-12-16 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20130017969A1 (de) |
| EP (1) | EP2513328A1 (de) |
| JP (1) | JP2013514070A (de) |
| KR (1) | KR20120115321A (de) |
| CN (1) | CN102762742A (de) |
| AU (1) | AU2010332876A1 (de) |
| BR (1) | BR112012014678A2 (de) |
| CA (1) | CA2783693A1 (de) |
| IN (1) | IN2012DN06279A (de) |
| MX (1) | MX2012006623A (de) |
| RU (1) | RU2012130069A (de) |
| WO (1) | WO2011073321A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10370714B2 (en) | 2011-06-27 | 2019-08-06 | Galderma Research & Development | Th-17 differentiation markers for rosacea and uses thereof |
| EP2723892A2 (de) * | 2011-06-27 | 2014-04-30 | Galderma Research & Development | Neue th-17-differenzierungsmarker für rosacea und ihre verwendung |
| CA2852160A1 (en) * | 2011-10-28 | 2013-05-02 | Galderma Research & Development | New leukocyte infiltrate markers for rosacea and uses thereof |
| EP2791354B1 (de) | 2011-12-16 | 2017-06-14 | Galderma Research & Development | Verfahren zur diagnose von rosacea |
| US9860241B2 (en) * | 2014-04-15 | 2018-01-02 | Level 3 Communications, Llc | Device registration, authentication, and authorization system and method |
| KR101712747B1 (ko) | 2015-11-06 | 2017-03-07 | 가톨릭대학교 산학협력단 | 유파틸린을 유효성분으로 포함하는 피부질환 예방 또는 치료용 조성물 |
| CN106119348B (zh) * | 2016-06-27 | 2018-02-23 | 中南大学湘雅医院 | 一种以非编码lnc‑CXCL1及编码基因cxcl1组合为检测或诊断筛查标志物的重症肌无力检测试剂盒及应用 |
| KR102216941B1 (ko) * | 2020-08-12 | 2021-02-18 | 주식회사 큐티스의생명연구센터 | 마이크로니들 패치를 포함하는 최소 침습적 홍조성 민감피부 평가 키트 및 홍조성 민감피부 평가를 위한 바이오마커 |
| US20230304091A1 (en) * | 2020-08-10 | 2023-09-28 | Cutis Biomedical Research Center | Minimally invasive kit for diagnosing skin condition, comprising microneedle patch |
| CN113462770B (zh) * | 2021-08-25 | 2023-03-31 | 中国医科大学附属第一医院 | 趋化因子作为玫瑰痤疮诊断的分子标志物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090118141A1 (en) * | 2005-05-04 | 2009-05-07 | The Regents Of The University Of California | Methods of oligosaccharide profiling for the detection of ocular rosacea |
| EP2124058B1 (de) * | 2006-01-05 | 2014-03-05 | Galderma Research & Development | Diagnostik von Akne mittels Biomarker für Verletzungen und Screenung von Modulatoren davon |
| EP2069377A4 (de) * | 2006-09-27 | 2009-11-11 | Univ California | Verfahren und zusammensetzungen zur behandlung von hautkrankheiten und hautfunktionsstörungen |
| EP2212442A1 (de) | 2007-10-26 | 2010-08-04 | Galderma Research & Development | Nicht-invasives verfahren zur durchführung von pharmakogenomischen studien über entzündliche hauterkrankungen und diagnoseverfahren dafür |
| FR2923610B1 (fr) | 2007-11-14 | 2009-11-27 | Galderma Res & Dev | Methode non-invasive de recueil de donnees biologiques pour l'etablissement d'un diagnostic d'une pathologie cutanee. |
-
2010
- 2010-12-16 IN IN6279DEN2012 patent/IN2012DN06279A/en unknown
- 2010-12-16 US US13/516,834 patent/US20130017969A1/en not_active Abandoned
- 2010-12-16 EP EP10788092A patent/EP2513328A1/de not_active Withdrawn
- 2010-12-16 KR KR1020127018566A patent/KR20120115321A/ko not_active Application Discontinuation
- 2010-12-16 JP JP2012543751A patent/JP2013514070A/ja active Pending
- 2010-12-16 RU RU2012130069/10A patent/RU2012130069A/ru not_active Application Discontinuation
- 2010-12-16 CA CA2783693A patent/CA2783693A1/en not_active Abandoned
- 2010-12-16 MX MX2012006623A patent/MX2012006623A/es not_active Application Discontinuation
- 2010-12-16 CN CN2010800573982A patent/CN102762742A/zh active Pending
- 2010-12-16 BR BR112012014678A patent/BR112012014678A2/pt not_active IP Right Cessation
- 2010-12-16 WO PCT/EP2010/069896 patent/WO2011073321A1/en active Application Filing
- 2010-12-16 AU AU2010332876A patent/AU2010332876A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013514070A (ja) | 2013-04-25 |
| CN102762742A (zh) | 2012-10-31 |
| EP2513328A1 (de) | 2012-10-24 |
| MX2012006623A (es) | 2012-11-30 |
| AU2010332876A1 (en) | 2012-07-12 |
| BR112012014678A2 (pt) | 2016-04-05 |
| US20130017969A1 (en) | 2013-01-17 |
| CA2783693A1 (en) | 2011-06-23 |
| KR20120115321A (ko) | 2012-10-17 |
| WO2011073321A1 (en) | 2011-06-23 |
| RU2012130069A (ru) | 2014-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN06279A (de) | ||
| MX2010003139A (es) | Agentes terapeuticos para la enfermedad de injerto contra hospedero que comprenden un inhibidor del receptor de interleucina 6 como ingrediente activo. | |
| MX2019013922A (es) | Inhibidores novedosos de map4k1. | |
| MX352614B (es) | Nuevos agentes anti-inflamatorios. | |
| NZ742819A (en) | Inhibitors of cxcr2 | |
| UA103634C2 (en) | Azaindazole compounds as ccr1 receptor antagonists | |
| EA201171074A1 (ru) | Цитотоксические конъюгаты с соединением, связывающим рецептор нейропептида y | |
| EA200970051A1 (ru) | Антагонист рецептора il-8 | |
| ECSP11011433A (es) | Fenilureas y fenilamidas sustituidas como ligandos del receptor de vanilloides | |
| CR10379A (es) | Composiones farmaceuticas de antagonistas del anticuerpo anti-cd40. | |
| EA201201541A1 (ru) | НОВЫЕ ПРОИЗВОДНЫЕ ЦИКЛОГЕКСИЛАМИНА, ОБЛАДАЮЩИЕ АГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К β2 АДРЕНЕРГИЧЕСКОМУ РЕЦЕПТОРУ И АНТАГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К M3 МУСКАРИНОВОМУ РЕЦЕПТОРУ | |
| CL2014001452A1 (es) | Compuestos derivados de dihidro-benzo-oxacina y dihidro-pirido-oxacina; composicion farmaceutica; metodo para modular la actividad de enzimas pi3k; metodo para el tratamiento; y uso para el tratamiento de artritis reumatoide, pénfigo vulgar, esclerosis multiple, miastenia grave, alergia y malaria, entre otras enfermedades. | |
| WO2011154139A3 (en) | Gene expression markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment | |
| SG154441A1 (en) | Treatment of demyelinating disorders | |
| WO2010044543A3 (ko) | 단백질 키나제 억제제로서 헤테로사이클릭 화합물 | |
| WO2012103360A3 (en) | Wnt compositions and methods of use thereof | |
| WO2007108936A3 (en) | N-substituted-azacyclylamines as histamine-3 antagonists | |
| WO2010112458A8 (en) | Composition and methods of use for therapeutic antibodies specific for the il-12 receptore betal subunit | |
| MX2010006089A (es) | Metodos de tratamiento de enfermedad pulmonar obstructiva cronica. | |
| WO2007136668A3 (en) | N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists | |
| WO2007015157A3 (en) | Mc4r-ag0nists for the treatment of urinary tract dysfunction | |
| MX2011012669A (es) | Nuevos agonistas del receptor de glucocorticoides. | |
| UA102231C2 (ru) | Применение фипронила для увеличения урожайности пшеницы и способ обработки пшеницы | |
| EA201001842A1 (ru) | Новые соединения, обладающие активностью антагонистов мускариновых рецепторов | |
| TNSN07462A1 (en) | Ampa receptor potentiators |